BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 10631149)

  • 21. The contribution of melanocortin 1 receptor gene polymorphisms and the agouti signalling protein gene 8818A>G polymorphism to cutaneous melanoma and basal cell carcinoma in a Polish population.
    Brudnik U; Branicki W; Wojas-Pelc A; Kanas P
    Exp Dermatol; 2009 Feb; 18(2):167-74. PubMed ID: 18637131
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High polymorphism at the human melanocortin 1 receptor locus.
    Rana BK; Hewett-Emmett D; Jin L; Chang BH; Sambuughin N; Lin M; Watkins S; Bamshad M; Jorde LB; Ramsay M; Jenkins T; Li WH
    Genetics; 1999 Apr; 151(4):1547-57. PubMed ID: 10101176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The melanocortin 1 receptor (MC1R): more than just red hair.
    Rees JL
    Pigment Cell Res; 2000 Jun; 13(3):135-40. PubMed ID: 10885670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The melanocortin-1-receptor gene is the major freckle gene.
    Bastiaens M; ter Huurne J; Gruis N; Bergman W; Westendorp R; Vermeer BJ; Bouwes Bavinck JN
    Hum Mol Genet; 2001 Aug; 10(16):1701-8. PubMed ID: 11487574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A polymorphism in the agouti signaling protein gene is associated with human pigmentation.
    Kanetsky PA; Swoyer J; Panossian S; Holmes R; Guerry D; Rebbeck TR
    Am J Hum Genet; 2002 Mar; 70(3):770-5. PubMed ID: 11833005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA polymorphism and selection at the melanocortin-1 receptor gene in normally pigmented southern African individuals.
    John PR; Makova K; Li WH; Jenkins T; Ramsay M
    Ann N Y Acad Sci; 2003 Jun; 994():299-306. PubMed ID: 12851329
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distribution of MC1R variants among melanoma subtypes: p.R163Q is associated with lentigo maligna melanoma in a Mediterranean population.
    Puig-Butillé JA; Carrera C; Kumar R; Garcia-Casado Z; Badenas C; Aguilera P; Malvehy J; Nagore E; Puig S
    Br J Dermatol; 2013 Oct; 169(4):804-11. PubMed ID: 23647022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Melanocortin 1 receptor and its influence on naevi and melanoma in dark-skinned phenotypes.
    Smith DJM
    Australas J Dermatol; 2019 Aug; 60(3):192-199. PubMed ID: 30585306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Melanocortin receptor-1 gene polymorphisms and the risk of cutaneous melanoma in a low-risk southern European population.
    Stratigos AJ; Dimisianos G; Nikolaou V; Poulou M; Sypsa V; Stefanaki I; Papadopoulos O; Polydorou D; Plaka M; Christofidou E; Gogas H; Tsoutsos D; Kastana O; Antoniou C; Hatzakis A; Kanavakis E; Katsambas AD
    J Invest Dermatol; 2006 Aug; 126(8):1842-9. PubMed ID: 16601669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MC1R, SLC45A2 and TYR genetic variants involved in melanoma susceptibility in southern European populations: results from a meta-analysis.
    Ibarrola-Villava M; Hu HH; Guedj M; Fernandez LP; Descamps V; Basset-Seguin N; Bagot M; Benssussan A; Saiag P; Fargnoli MC; Peris K; Aviles JA; Lluch A; Ribas G; Soufir N
    Eur J Cancer; 2012 Sep; 48(14):2183-91. PubMed ID: 22464347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of MC1R variants and host phenotypes with melanoma risk in CDKN2A mutation carriers: a GenoMEL study.
    Demenais F; Mohamdi H; Chaudru V; Goldstein AM; Newton Bishop JA; Bishop DT; Kanetsky PA; Hayward NK; Gillanders E; Elder DE; Avril MF; Azizi E; van Belle P; Bergman W; Bianchi-Scarrà G; Bressac-de Paillerets B; Calista D; Carrera C; Hansson J; Harland M; Hogg D; Höiom V; Holland EA; Ingvar C; Landi MT; Lang JM; Mackie RM; Mann GJ; Ming ME; Njauw CJ; Olsson H; Palmer J; Pastorino L; Puig S; Randerson-Moor J; Stark M; Tsao H; Tucker MA; van der Velden P; Yang XR; Gruis N;
    J Natl Cancer Inst; 2010 Oct; 102(20):1568-83. PubMed ID: 20876876
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of polymorphic variants in the melanocortin-1 receptor gene with cutaneous pigmentation using an evolutionary approach.
    Kanetsky PA; Ge F; Najarian D; Swoyer J; Panossian S; Schuchter L; Holmes R; Guerry D; Rebbeck TR
    Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):808-19. PubMed ID: 15159314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population.
    Landi MT; Kanetsky PA; Tsang S; Gold B; Munroe D; Rebbeck T; Swoyer J; Ter-Minassian M; Hedayati M; Grossman L; Goldstein AM; Calista D; Pfeiffer RM
    J Natl Cancer Inst; 2005 Jul; 97(13):998-1007. PubMed ID: 15998953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An ultraviolet-radiation-independent pathway to melanoma carcinogenesis in the red hair/fair skin background.
    Mitra D; Luo X; Morgan A; Wang J; Hoang MP; Lo J; Guerrero CR; Lennerz JK; Mihm MC; Wargo JA; Robinson KC; Devi SP; Vanover JC; D'Orazio JA; McMahon M; Bosenberg MW; Haigis KM; Haber DA; Wang Y; Fisher DE
    Nature; 2012 Nov; 491(7424):449-53. PubMed ID: 23123854
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Susceptibility to melanoma: influence of skin type and polymorphism in the melanocyte stimulating hormone receptor gene.
    Ichii-Jones F; Lear JT; Heagerty AH; Smith AG; Hutchinson PE; Osborne J; Bowers B; Jones PW; Davies E; Ollier WE; Thomson W; Yengi L; Bath J; Fryer AA; Strange RC
    J Invest Dermatol; 1998 Aug; 111(2):218-21. PubMed ID: 9699720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MC1R variation and melanoma risk in the Swedish population in relation to clinical and pathological parameters.
    Höiom V; Tuominen R; Käller M; Lindén D; Ahmadian A; Månsson-Brahme E; Egyhazi S; Sjöberg K; Lundeberg J; Hansson J
    Pigment Cell Melanoma Res; 2009 Apr; 22(2):196-204. PubMed ID: 19077144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Four novel variants in MC1R in red-haired South African individuals of European descent: S83P, Y152X, A171D, P256S.
    John PR; Ramsay M
    Hum Mutat; 2002 Apr; 19(4):461-2. PubMed ID: 11933208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contribution of melanocortin-1 receptor gene variants to sporadic cutaneous melanoma risk in a population in central Italy: a case-control study.
    Fargnoli MC; Altobelli E; Keller G; Chimenti S; Höfler H; Peris K
    Melanoma Res; 2006 Apr; 16(2):175-82. PubMed ID: 16567973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Associations of 9p21 variants with cutaneous malignant melanoma, nevi, and pigmentation phenotypes in melanoma-prone families with and without CDKN2A mutations.
    Yang XR; Liang X; Pfeiffer RM; Wheeler W; Maeder D; Burdette L; Yeager M; Chanock S; Tucker MA; Goldstein AM
    Fam Cancer; 2010 Dec; 9(4):625-33. PubMed ID: 20574843
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic determinants of hair, eye and skin pigmentation in Europeans.
    Sulem P; Gudbjartsson DF; Stacey SN; Helgason A; Rafnar T; Magnusson KP; Manolescu A; Karason A; Palsson A; Thorleifsson G; Jakobsdottir M; Steinberg S; Pálsson S; Jonasson F; Sigurgeirsson B; Thorisdottir K; Ragnarsson R; Benediktsdottir KR; Aben KK; Kiemeney LA; Olafsson JH; Gulcher J; Kong A; Thorsteinsdottir U; Stefansson K
    Nat Genet; 2007 Dec; 39(12):1443-52. PubMed ID: 17952075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.